GlobeNewswire
-
BioSyent Releases Financial Results for Q3 and YTD 2026
17/11/2026 -
BioSyent Declares Fourth Quarter 2026 Dividend
17/11/2026 -
Biogen’s Diranersen Demonstrates Increasing Clinical Benefit at Two Years in Early Alzheimer’s Disease
17/11/2026 -
InspireMD to Host KOL Webinar on Carotid Artery Disease Management and the Clinical Benefits of InspireMD’s CGuard Prime Carotid Stent Platform
17/11/2026 -
Gain Therapeutics Presents Clinical Data from Phase 1b Study of Rexaceract and Preclinical Data from Novel GCase Modulator GT-04686
17/11/2026 -
CytomX Therapeutics Announces Milestone Achievement in Strategic Collaboration with Regeneron in the Field of Conditionally Activated Bispecifics
17/11/2026 -
CVRx to Participate at the Piper Sandler 38th Annual Healthcare Conference
17/11/2026 -
PacBio to Participate in the Piper Sandler 38th Annual Healthcare Conference
17/11/2026 -
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
17/11/2026 -
Inspire Medical Systems, Inc. to Present at the Piper Sandler 38th Annual Healthcare Conference
17/11/2026 -
Iridex Reports Third Quarter 2026 Financial Results
17/11/2026 -
Mobia Medical to Participate in the Piper Sandler 38th Annual Healthcare Conference
17/11/2026 -
Elutia Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
17/11/2026 -
Akebia Therapeutic’s Vafseo® (vadadustat) Granted Additional Patent
17/11/2026 -
Amneal Announces European Approval of Adcomfo® (Omalizumab), a Biosimilar to XOLAIR®
17/11/2026 -
Windward Bio to Participate at the Jefferies London Global Healthcare Conference
17/11/2026 -
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
17/11/2026 -
SELLAS Life Sciences Announces Proposed $150.0 Million Underwritten Public Offering
17/11/2026 -
COP31 : l’EAACI appelle à intégrer les allergies et la santé respiratoire dans les politiques de lutte contre le changement climatique
17/11/2026
Pages